Similar articles

• Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.

  Brattsand R, Harthon L. Brattsand R, et al. Arzneimittelforschung. 1971 Sep;21(9):1335-8. Arzneimittelforschung. 1971. PMID: 5171788 No abstract available.
• Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.

  Lan SJ, Chando TJ, Weliky I, Schreiber EC. Lan SJ, et al. J Pharmacol Exp Ther. 1973 Aug;186(2):323-30. J Pharmacol Exp Ther. 1973. PMID: 4719785 No abstract available.
• Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.

  Harthon L, Svedmyr N. Harthon L, et al. Atherosclerosis. 1974 Jul-Aug;20(1):65-8. doi: 10.1016/0021-9150(74)90079-3. Atherosclerosis. 1974. PMID: 4617581 Clinical Trial. No abstract available.
• Some aspects of sorbinicate pharmacokinetics.

  Subissi A, Biagi M, Murmann W. Subissi A, et al. Arzneimittelforschung. 1980;30(8):1278-84. Arzneimittelforschung. 1980. PMID: 7192142
• Metabolic disposition of antihyperlipidemic agents in man and laboratory animals.

  Cayen MN. Cayen MN. Drug Metab Rev. 1980;11(2):291-323. doi: 10.3109/03602538008994028. Drug Metab Rev. 1980. PMID: 7011761 Review. No abstract available.